Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Synergy Pharmaceuticals Acquires FV-100 Shingles Drug From Bristol-Myers Squibb Company
Fierce Biotech
Saturday, August 25, 2012 - 12:49pm
tags:
Synergy Pharmaceuticals, Bristol-Myers Squibb, shingles, FV-100
JPMorgan Chase Raises Price Target on Watson Pharmaceuticals Incorporated (WPI)
Daily Political
Saturday, August 25, 2012 - 12:46pm
tags:
Watson Pharmaceuticals
Medicis reports lower Q2 net income, provides guidance for Q3 and 2012
Equities.com
Saturday, August 25, 2012 - 12:44pm
tags:
Medicis, earnings
4 Pharmaceutical Stocks to Sell Now
InvestorPlace
Saturday, August 25, 2012 - 12:43pm
tags:
Warner Chilcott, Shire, Sagent Pharmaceuticals, Pemix Therapeutic Holdings
U.S. Court of Appeals Upholds Validity of Lilly's Alimta Compound Patent
PR NewsWire
Saturday, August 25, 2012 - 12:42pm
tags:
Eli Lilly, Alimta, patents
Boehringer, Bayer Blood Thinners Backed For Arrhythmia
Bloomberg
Saturday, August 25, 2012 - 12:10pm
tags:
Boehringer Ingelheim, Bayer, atrial fibrillation
Do We Really Need Another Injected Rheumatoid Arthritis Drug?
Motley Fool
Saturday, August 25, 2012 - 12:04pm
tags:
rheumatoid arthritis, sirukumab
Pfizer's New Business Model Makes For An Ideal Investment
Seeking Alpha
Saturday, August 25, 2012 - 12:02pm
tags:
Pfizer
Omnicare Agrees To Settle Suit Over Reimbursement Claims
Bloomberg
Saturday, August 25, 2012 - 12:01pm
tags:
Omnicare, lawsuits
Bristol-Myers Squibb Company (BMY): Today's Featured Health Care Winner
The Street
Saturday, August 25, 2012 - 11:59am
tags:
Bristol-Myers Squibb
Pfizer Inc (PFE): Today's Featured Drugs Winner
The Street
Saturday, August 25, 2012 - 11:58am
tags:
Pfizer
Jim Simons’ Favorite Pharma Duo
Motley Fool
Saturday, August 25, 2012 - 11:56am
tags:
Bristol-Myers Squibb, Eli Lilly
3 Reasons Pfizer Should Partner With MannKind
Motley Fool
Saturday, August 25, 2012 - 11:52am
tags:
Pfizer, MannKind, Afrezza
Arena Is Poised To Move
Seeking Alpha
Saturday, August 25, 2012 - 11:50am
tags:
Arena Pharmaceuticals
5 High-Growth Biotechnology Stocks That Analysts Strongly Favor
Seeking Alpha
Saturday, August 25, 2012 - 11:41am
tags:
Pain Therapeutics, Cerus, Zalicus, Merrimack Pharmaceuticals, Cell Therapeutics
Is YM BioSciences the Perfect Penny Stock?
Motley Fool
Saturday, August 25, 2012 - 11:39am
tags:
YM BioSciences
This Just In: More Upgrades and Downgrades
Motley Fool
Saturday, August 25, 2012 - 11:38am
tags:
Discovery Labs, Oncothyreon, Threshold Pharmaceuticals, Puma Biotechnology, Immunogen, Pharmacyclics, Infinity Pharmaceuticals
Maxim Group Highlights 3 Biotech Stocks With Key Milestones Ahead
Seeking Alpha
Saturday, August 25, 2012 - 11:35am
tags:
Ariad, Exelixis, Medgenics
Pluristem to Begin IC Phase II Trial
Yahoo/Zacks
Saturday, August 25, 2012 - 11:34am
tags:
Pluristem, intermittent claudication, placental expanded cells
Healthcare Sector Undervalued, 3 Stocks With Mixed Upside
Motley Fool
Saturday, August 25, 2012 - 11:32am
tags:
Bristol-Myers Squibb, Amgen, Baxter

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.